Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2020-09-29 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated September 29, 2020, addressed to stock exchanges regarding the schedule of analyst/institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about informing the exchanges of upcoming investor meetings, specifically a conference call with Earnest Innovation Partners. There is no financial data, no detailed report, no voting results, no management changes, and no legal or capital structure updates. The document is brief (1636 characters) and serves as an announcement of a scheduled event rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated September 25, 2020, addressed to stock exchanges, informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an announcement of scheduled conference calls with investors and analysts, with no financial data, report, or detailed presentation included. The document length is only 1699 characters, indicating it is a brief notice rather than a full report or transcript. Therefore, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and disclosure, not a Call Transcript (CT) or Investor Presentation (IP).
2020-09-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated September 23, 2020, addressed to stock exchanges, informing about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an announcement of scheduled meetings with no financial data, no detailed presentation, no voting results, no management discussion, and no report attached or referenced as being published. The document length is only 2043 characters, which is quite short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories like Investor Presentation or Call Transcript.
2020-09-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated September 21, 2020, addressed to stock exchanges, informing about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an announcement of scheduled investor meetings and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report content included. The document length is 1928 characters, which is short and consistent with an announcement rather than a full report or transcript. Therefore, this document fits the category of Investor Presentation announcements or meeting schedule notifications. However, since it is only a schedule notice and not the presentation itself, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-09-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated September 17, 2020, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is about informing the stock exchanges of upcoming investor meetings, specifically a conference call with Mirae Asset Management on September 18, 2020. There is no financial data, no detailed report, no voting results, no management changes, or other substantive filings. The document is essentially an announcement or intimation of a scheduled event rather than a report or transcript. Given the short length (1628 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated September 11, 2020, addressed to stock exchanges regarding the schedule of analyst/institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about informing the stock exchanges of upcoming investor meetings, specifically a conference call scheduled for September 14, 2020. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content. The document is essentially an announcement of an event related to investor relations. Given the short length (1615 characters) and the nature of the content, it does not qualify as a financial report, earnings release, or call transcript. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2020-09-11 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.